Beyond Medical Technologies Inc (DE:7FM0)
FRANKFURT:7FM0
Total Valuation
Beyond Medical Technologies Inc has a market cap or net worth of €2.13M. The enterprise value is €2.54M.
Market Cap€2.13M
Enterprise Value€2.54M
Share Statistics
Beyond Medical Technologies Inc has 32,793,960 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding32,793,960
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Beyond Medical Technologies Inc’s return on equity (ROE) is <0.01 and return on invested capital (ROIC) is 78.30%.
Return on Equity (ROE)<0.01
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)78.30%
Return on Capital Employed (ROCE)0.71
Revenue Per Employee0.00
Profits Per Employee-121.96K
Employee Count3
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Beyond Medical Technologies Inc is ―. Beyond Medical Technologies Inc’s PEG ratio is 0.02.
PE Ratio―
PS Ratio0.00
PB Ratio-0.45
Price to Fair Value-0.45
Price to FCF-2.52
Price to Operating Cash Flow-7.25
PEG Ratio0.02
Income Statement
In the last 12 months, Beyond Medical Technologies Inc had revenue of 0.00 and earned -285.00 in profits. Earnings per share was -0.04.
Revenue0.00
Gross Profit0.00
Operating Income-438.99K
Pretax Income-365.88K
Net Income-285.00
EBITDA-365.88K
Earnings Per Share (EPS)-0.04
Cash Flow
In the last 12 months, operating cash flow was -470.33K and capital expenditures -1.00, giving a free cash flow of -470.33K billion.
Operating Cash Flow-470.33K
Free Cash Flow-470.33K
Free Cash Flow per Share-0.01
Dividends & Yields
Beyond Medical Technologies Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta21.44
52-Week Price Change-88.04%
50-Day Moving Average0.08
200-Day Moving Average0.16
Relative Strength Index (RSI)33.68
Average Volume (3m)1.54K
Important Dates
Beyond Medical Technologies Inc upcoming earnings date is Aug 31, 2026, TBA (Confirmed).
Last Earnings DateJun 1, 2026
Next Earnings DateAug 31, 2026
Ex-Dividend Date―
Financial Position
Beyond Medical Technologies Inc as a current ratio of 0.02, with Debt / Equity ratio of 67.29%
Current Ratio0.02
Quick Ratio0.02
Debt to Market Cap0.22
Net Debt to EBITDA-0.13
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Beyond Medical Technologies Inc has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Beyond Medical Technologies Inc EV to EBITDA ratio is -0.88, with an EV/FCF ratio of -2.95.
EV to Sales0.00
EV to EBITDA-0.88
EV to Free Cash Flow-2.95
EV to Operating Cash Flow-2.95
Balance Sheet
Beyond Medical Technologies Inc has €7.06M in cash and marketable securities with €1.27M in debt, giving a net cash position of €5.80M billion.
Cash & Marketable Securities€7.06M
Total Debt€1.27M
Net Cash€5.80M
Net Cash Per Share€0.18
Tangible Book Value Per Share-€0.08
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Beyond Medical Technologies Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast-47.66%